Trial Outcomes & Findings for Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2 (NCT NCT01684046)

NCT ID: NCT01684046

Last Updated: 2014-04-29

Results Overview

Lens wear comfort was assessed by the participant on a 5-point Likert scale. The participant was instructed to select a single response to the statement, "When I use this solution, I can comfortably wear my lenses," with 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, and 5 = strongly agree.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

196 participants

Primary outcome timeframe

Day 30

Results posted on

2014-04-29

Participant Flow

Participants were recruited from 5 study centers located in the US, 2 study centers located in the UK, and 3 study centers located in Germany.

Of the 196 enrolled, 4 participants were exited as screen failures prior to randomization. This reporting group includes all randomized participants who were exposed to a study regimen (test or control) (192).

Participant milestones

Participant milestones
Measure
PureMoist - RevitaLens
Opti-Free® PureMoist® MPDS, followed by RevitaLens MPDS. Each product used as indicated for 30 days with participant's habitual contact lenses.
RevitaLens - PureMoist
RevitaLens MPDS, followed by Opti-Free® PureMoist® MPDS. Each product used as indicated for 30 days with participant's habitual contact lenses.
Period 1, First 30 Days
STARTED
97
95
Period 1, First 30 Days
COMPLETED
97
93
Period 1, First 30 Days
NOT COMPLETED
0
2
Period 2, Second 30 Days
STARTED
97
93
Period 2, Second 30 Days
COMPLETED
97
93
Period 2, Second 30 Days
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
PureMoist - RevitaLens
Opti-Free® PureMoist® MPDS, followed by RevitaLens MPDS. Each product used as indicated for 30 days with participant's habitual contact lenses.
RevitaLens - PureMoist
RevitaLens MPDS, followed by Opti-Free® PureMoist® MPDS. Each product used as indicated for 30 days with participant's habitual contact lenses.
Period 1, First 30 Days
Adverse Event
0
2

Baseline Characteristics

Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PureMoist / RevitaLens
n=192 Participants
Opti-Free® PureMoist® MPDS and RevitaLens MPDS used during Period 1 and Period 2 in randomized order in crossover assignment.
Age, Continuous
32.0 years
STANDARD_DEVIATION 11.42 • n=5 Participants
Sex: Female, Male
Female
142 Participants
n=5 Participants
Sex: Female, Male
Male
50 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 30

Population: This analysis population includes all participants who were exposed to study regimen (test and control) and completed both study periods, excluding major protocol deviations.

Lens wear comfort was assessed by the participant on a 5-point Likert scale. The participant was instructed to select a single response to the statement, "When I use this solution, I can comfortably wear my lenses," with 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, and 5 = strongly agree.

Outcome measures

Outcome measures
Measure
PureMoist
n=183 Participants
Opti-Free® PureMoist® MPDS used during Period 1 or Period 2 for 30 days with participant's habitual contact lenses.
RevitaLens
n=183 Participants
RevitaLens MPDS used during Period 1 or Period 2 for 30 days with participant's habitual contact lenses.
Subjective Lens Wear Comfort
4.3 units on a scale
Standard Deviation 0.89
4.3 units on a scale
Standard Deviation 0.72

Adverse Events

PureMoist

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

RevitaLens

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jessie Lemp, GMA Brand Lead

Alcon Research, Ltd.

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER